Christophe Dooms

photo

Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE)

UZ Herestraat 49 - box 7003

3000 Leuven

KU Leuven map

Functions


Curriculum Vitae

 

 

Recent publications

  • launch Vandervelde, C.M., Everaerts, S., Weder, W., Orolé, S., Hermans, P-J., De Leyn, P., Nafteux, P., Decaluwé, H., Van Veer, H., Depypere, L., Coppens, S., Neyrinck, A.P., Bouneb, S., De Coster, J., Coolen, J., Dooms, C., Van Raemdonck, D.E., Janssens, W., Ceulemans, L.J. (2024). Implementation of an enhanced recovery protocol for lung volume reduction surgery: an observational cohort study. Eur J Cardiothorac Surg. doi: 10.1093/ejcts/ezae109
  • launch Drilon, A., Camidge, D.R., Lin, J.J., Kim, S-W., Solomon, B.J., Dziadziuszko, R., Besse, B., Goto, K., de Langen, A.J., Wolf, J., Lee, K.H., Popat, S., Springfeld, C., Nagasaka, M., Felip, E., Yang, N., Velcheti, V., Lu, S., Kao, S., Dooms, C., Krebs, M.G., Yao, W., Beg, M.S., Hu, X., Moro-Sibilot, D., Cheema, P., Stopatschinskaja, S., Mehta, M., Trone, D., Graber, A., Sims, G., Yuan, Y., Cho, B.C., TRIDENT-1 Investigators, (2024). Repotrectinib in ROS1 Fusion-Positive Non-Small-Cell Lung Cancer. N Engl J Med, 390 (2), 118-131. doi: 10.1056/NEJMoa2302299
  • launch Dy, G.K., Govindan, R., Velcheti, V., Falchook, G.S., Italiano, A., Wolf, J., Sacher, A.G., Takahashi, T., Ramalingam, S.S., Dooms, C., Kim, D-W., Addeo, A., Desai, J., Schuler, M., Tomasini, P., Hong, D.S., Lito, P., Tran, Q., Jones, S., Anderson, A., Hindoyan, A., Snyder, W., Skoulidis, F., Li, B.T. with Dy, G.K. (corresp. author) (2024). Long-term benefit of sotorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: plain language summary. FUTURE ONCOLOGY, 20 (3), 113-120. doi: 10.2217/fon-2023-0560 openaccessvia repository
  • launch Cassier, P., Dooms, C., Gazzah, A., Felip, E., Steeghs, N., Rohrberg, K.S., De Braud, F., Solomon, B., Schuler, M., Tan, D.S., Yamamoto, N., Loong, H.H F., Cho, B.C., Wolf, J., Lin, C.C., Negrao, M.V., Werner, L., Cui, X., Farago, A.F., DeMiguel, M.J. (2024). KontRASt-01 Update: Safety and Efficacy of JDQ443 in KRAS G12C-Mutated Solid Tumors Including Non-Small Cell Lung Cancer (NSCLC). In: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS: vol. 118 (1), (E4-E5). Presented at the Multidisciplinary Thoracic Cancers Symposium, LA, New Orleans, 30 Nov 2023-02 Dec 2023.
  • launch Hochmair, M.J., Vermaelen, K., Mountzios, G., Carcereny, E., Dooms, C., Lee, S-H., Morocz, E.M., Kato, T., Ciuleanu, T-E., Dy, G., Parente, M.B M C S., O'Byrne, K.J., Chu, Q.S-C., De Castro Jr, G., Girard, N., Snyder, W., Tran, Q., Kormany, W., Houk, B., Curioni-Fontecedro, A. with Hochmair, M.J. (corresp. author) (2024). VP4-2023: Sotorasib 960 mg versus 240 mg in pretreated KRAS G12C advanced NSCLC. ANNALS OF ONCOLOGY, 35 (1), 142-144. doi: 10.1016/j.annonc.2023.10.790
  • launch Goto, K., Novello, S., Garrido Lopez, P., Dooms, C., Alatorre Alexander, J.A., Reinmuth, N., Gilligan, A., Payakachat, N., Lin, A., Cocks, K., Worthy, G., Zhou, C. (2023). Patient-reported outcomes of first-line selpercatinib versus chemotherapy with or without pembrolizumab in RET fusion-positive advanced non-small cell lung cancer: Interim analysis of LIBRETTO-431. In: ANNALS OF ONCOLOGY: vol. 34, (S1654-S1655). Presented at the Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), SINGAPORE, 01 Dec 2023-03 Dec 2023. doi: 10.1016/j.annonc.2023.10.566
  • launch Negrao, M.V., Cassier, P.A., Solomon, B., Schuler, M., Rohrberg, K., Cresta, S., Dooms, C., Tan, D.S W., Loong, H.H-F., Amatu, A., Assmann, K.K., Fairchild, L., Sansregret, L., Fan, L., Farago, A.F., Cho, B.C. (2023). KontRASt-01: Preliminary Safety and Efficacy of JDQ443+TNO155 in Patients with Advanced, KRAS G12C-Mutated Solid Tumors. In: JOURNAL OF THORACIC ONCOLOGY: vol. 18 (11), (S117-S118).
  • launch Schuler, M., Cassier, P.A., Dooms, C., Gazzah, A., Felip, E., Steeghs, N., Rohrberg, K.S., De Braud, F., Solomon, B., Tan, D.S., Yamamoto, N., Loong, H.H., Cho, B.C., Wolf, J., Lin, C-C., Negrao, M., Werner, L., Cui, X., Farago, A.F., de Miguel, M.J. (2023). KontRASt-01 update: safety and efficacy of JDQ443 in KRAS G12C-mutated solid tumors including non-small cell lung cancer (NSCLC). In: ONCOLOGY RESEARCH AND TREATMENT: vol. 46, (147-148).
  • launch Spicer, J.D., Gao, S., Liberman, M., Kato, T., Tsuboi, M., Lee, S.H., Chen, K.N., Dooms, C., Majem, M., Eigendorff, E., Martinengo, G., Bylicki, O., Garassino, M.C., Abreu, D.R., Chaft, J., Novello, S., Yang, J., Keller, S.M., Samkari, A., Wakelee, H. (2023). Overall survival in the KEYNOTE-671 study of perioperative pembrolizumab for early-stage non-small-cell lung cancer NSCLC). In: ANNALS OF ONCOLOGY: vol. 34, (S1297-S1298). Presented at the Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), SPAIN, Barcelona, 20 Oct 2023-24 Oct 2023. doi: 10.1016/j.annonc.2023.10.052
  • launch Wakelee, H., Liberman, M., Kato, T., Tsuboi, M., Lee, S-H., Gao, S., Chen, K-N., Dooms, C., Majem, M., Eigendorff, E., Martinengo, G.L., Bylicki, O., Rodriguez-Abreu, D., Chaft, J.E E., Novello, S., Yang, J., Keller, S.M M., Samkari, A., Spicer, J.D D. with Wakelee, H. (corresp. author) (2023). Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer. NEW ENGLAND JOURNAL OF MEDICINE, 389 (6), 491-503. doi: 10.1056/NEJMoa2302983
  • E07S8A  Aanvullingen in de pneumologie
  • E03U2A  Probleemoplossend vermogen en vaardigheden in de pneumologie
  • E06Y0A  Vaardigheden en communicatie - 2
  • E07Y0B  Vaardigheden en communicatie - 3
  • E0C00A  Ademhaling
  • E0C93A  Respiratory Diseases
  • E0AM6A  Probleemoplossend vermogen in de interne geneeskunde, deel 1
  • E07S8B  Aanvullingen in de pneumologie
  • E0AX2A  Probleemoplossend vermogen in de interne geneeskunde, deel 2
  • E0BB2A  Probleemoplossend vermogen in de interne geneeskunde, deel 3
  • E0BS4A  Probleemoplossend vermogen in de pneumologie, deel 1
  • E0BU2A  Probleemoplossend vermogen in de pneumologie, deel 2
  • E0BZ0A  Probleemoplossend vermogen in de pneumologie, deel 3
  • E0C63B  Geïntegreerd klinisch onderzoek en redeneren (stationsproef) (masterproef deel 1)
  • E0I45A  Vaardigheden 1

Recent publications

  • launch Vandervelde, C.M., Everaerts, S., Weder, W., Orolé, S., Hermans, P-J., De Leyn, P., Nafteux, P., Decaluwé, H., Van Veer, H., Depypere, L., Coppens, S., Neyrinck, A.P., Bouneb, S., De Coster, J., Coolen, J., Dooms, C., Van Raemdonck, D.E., Janssens, W., Ceulemans, L.J. (2024). Implementation of an enhanced recovery protocol for lung volume reduction surgery: an observational cohort study. Eur J Cardiothorac Surg. doi: 10.1093/ejcts/ezae109
  • launch Drilon, A., Camidge, D.R., Lin, J.J., Kim, S-W., Solomon, B.J., Dziadziuszko, R., Besse, B., Goto, K., de Langen, A.J., Wolf, J., Lee, K.H., Popat, S., Springfeld, C., Nagasaka, M., Felip, E., Yang, N., Velcheti, V., Lu, S., Kao, S., Dooms, C., Krebs, M.G., Yao, W., Beg, M.S., Hu, X., Moro-Sibilot, D., Cheema, P., Stopatschinskaja, S., Mehta, M., Trone, D., Graber, A., Sims, G., Yuan, Y., Cho, B.C., TRIDENT-1 Investigators, (2024). Repotrectinib in ROS1 Fusion-Positive Non-Small-Cell Lung Cancer. N Engl J Med, 390 (2), 118-131. doi: 10.1056/NEJMoa2302299
  • launch Dy, G.K., Govindan, R., Velcheti, V., Falchook, G.S., Italiano, A., Wolf, J., Sacher, A.G., Takahashi, T., Ramalingam, S.S., Dooms, C., Kim, D-W., Addeo, A., Desai, J., Schuler, M., Tomasini, P., Hong, D.S., Lito, P., Tran, Q., Jones, S., Anderson, A., Hindoyan, A., Snyder, W., Skoulidis, F., Li, B.T. with Dy, G.K. (corresp. author) (2024). Long-term benefit of sotorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: plain language summary. FUTURE ONCOLOGY, 20 (3), 113-120. doi: 10.2217/fon-2023-0560 openaccessvia repository
  • launch Cassier, P., Dooms, C., Gazzah, A., Felip, E., Steeghs, N., Rohrberg, K.S., De Braud, F., Solomon, B., Schuler, M., Tan, D.S., Yamamoto, N., Loong, H.H F., Cho, B.C., Wolf, J., Lin, C.C., Negrao, M.V., Werner, L., Cui, X., Farago, A.F., DeMiguel, M.J. (2024). KontRASt-01 Update: Safety and Efficacy of JDQ443 in KRAS G12C-Mutated Solid Tumors Including Non-Small Cell Lung Cancer (NSCLC). In: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS: vol. 118 (1), (E4-E5). Presented at the Multidisciplinary Thoracic Cancers Symposium, LA, New Orleans, 30 Nov 2023-02 Dec 2023.
  • launch Hochmair, M.J., Vermaelen, K., Mountzios, G., Carcereny, E., Dooms, C., Lee, S-H., Morocz, E.M., Kato, T., Ciuleanu, T-E., Dy, G., Parente, M.B M C S., O'Byrne, K.J., Chu, Q.S-C., De Castro Jr, G., Girard, N., Snyder, W., Tran, Q., Kormany, W., Houk, B., Curioni-Fontecedro, A. with Hochmair, M.J. (corresp. author) (2024). VP4-2023: Sotorasib 960 mg versus 240 mg in pretreated KRAS G12C advanced NSCLC. ANNALS OF ONCOLOGY, 35 (1), 142-144. doi: 10.1016/j.annonc.2023.10.790
  • launch Goto, K., Novello, S., Garrido Lopez, P., Dooms, C., Alatorre Alexander, J.A., Reinmuth, N., Gilligan, A., Payakachat, N., Lin, A., Cocks, K., Worthy, G., Zhou, C. (2023). Patient-reported outcomes of first-line selpercatinib versus chemotherapy with or without pembrolizumab in RET fusion-positive advanced non-small cell lung cancer: Interim analysis of LIBRETTO-431. In: ANNALS OF ONCOLOGY: vol. 34, (S1654-S1655). Presented at the Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), SINGAPORE, 01 Dec 2023-03 Dec 2023. doi: 10.1016/j.annonc.2023.10.566
  • launch Negrao, M.V., Cassier, P.A., Solomon, B., Schuler, M., Rohrberg, K., Cresta, S., Dooms, C., Tan, D.S W., Loong, H.H-F., Amatu, A., Assmann, K.K., Fairchild, L., Sansregret, L., Fan, L., Farago, A.F., Cho, B.C. (2023). KontRASt-01: Preliminary Safety and Efficacy of JDQ443+TNO155 in Patients with Advanced, KRAS G12C-Mutated Solid Tumors. In: JOURNAL OF THORACIC ONCOLOGY: vol. 18 (11), (S117-S118).
  • launch Schuler, M., Cassier, P.A., Dooms, C., Gazzah, A., Felip, E., Steeghs, N., Rohrberg, K.S., De Braud, F., Solomon, B., Tan, D.S., Yamamoto, N., Loong, H.H., Cho, B.C., Wolf, J., Lin, C-C., Negrao, M., Werner, L., Cui, X., Farago, A.F., de Miguel, M.J. (2023). KontRASt-01 update: safety and efficacy of JDQ443 in KRAS G12C-mutated solid tumors including non-small cell lung cancer (NSCLC). In: ONCOLOGY RESEARCH AND TREATMENT: vol. 46, (147-148).
  • launch Spicer, J.D., Gao, S., Liberman, M., Kato, T., Tsuboi, M., Lee, S.H., Chen, K.N., Dooms, C., Majem, M., Eigendorff, E., Martinengo, G., Bylicki, O., Garassino, M.C., Abreu, D.R., Chaft, J., Novello, S., Yang, J., Keller, S.M., Samkari, A., Wakelee, H. (2023). Overall survival in the KEYNOTE-671 study of perioperative pembrolizumab for early-stage non-small-cell lung cancer NSCLC). In: ANNALS OF ONCOLOGY: vol. 34, (S1297-S1298). Presented at the Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), SPAIN, Barcelona, 20 Oct 2023-24 Oct 2023. doi: 10.1016/j.annonc.2023.10.052
  • launch Wakelee, H., Liberman, M., Kato, T., Tsuboi, M., Lee, S-H., Gao, S., Chen, K-N., Dooms, C., Majem, M., Eigendorff, E., Martinengo, G.L., Bylicki, O., Rodriguez-Abreu, D., Chaft, J.E E., Novello, S., Yang, J., Keller, S.M M., Samkari, A., Spicer, J.D D. with Wakelee, H. (corresp. author) (2023). Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer. NEW ENGLAND JOURNAL OF MEDICINE, 389 (6), 491-503. doi: 10.1056/NEJMoa2302983
  • E07S8A  Aanvullingen in de pneumologie
  • E03U2A  Probleemoplossend vermogen en vaardigheden in de pneumologie
  • E06Y0A  Vaardigheden en communicatie - 2
  • E07Y0B  Vaardigheden en communicatie - 3
  • E0C00A  Ademhaling
  • E0C93A  Respiratory Diseases
  • E0AM6A  Probleemoplossend vermogen in de interne geneeskunde, deel 1
  • E07S8B  Aanvullingen in de pneumologie
  • E0AX2A  Probleemoplossend vermogen in de interne geneeskunde, deel 2
  • E0BB2A  Probleemoplossend vermogen in de interne geneeskunde, deel 3
  • E0BS4A  Probleemoplossend vermogen in de pneumologie, deel 1
  • E0BU2A  Probleemoplossend vermogen in de pneumologie, deel 2
  • E0BZ0A  Probleemoplossend vermogen in de pneumologie, deel 3
  • E0C63B  Geïntegreerd klinisch onderzoek en redeneren (stationsproef) (masterproef deel 1)
  • E0I45A  Vaardigheden 1